Eduardo Bruno Martins - Net Worth and Insider Trading
Eduardo Bruno Martins Net Worth
The estimated net worth of Eduardo Bruno Martins is at least $267,191 dollars as of 2024-09-20. Eduardo Bruno Martins is the Chief Medical Officer of Sagimet Biosciences Inc and owns about 81,213 shares of Sagimet Biosciences Inc (SGMT) stock worth over $267,191. Details can be seen in Eduardo Bruno Martins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eduardo Bruno Martins has not made any transactions after 2024-07-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eduardo Bruno Martins
Eduardo Bruno Martins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eduardo Bruno Martins owns 2 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , and Sagimet Biosciences Inc (SGMT) .
Click here to see the complete history of Eduardo Bruno Martins’s form 4 insider trades.
Insider Ownership Summary of Eduardo Bruno Martins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2016-03-22 | SVP & Liver and Infectious Dise |
| SGMT | Sagimet Biosciences Inc | 2024-07-19 | director |
Eduardo Bruno Martins Latest Holdings Summary
Eduardo Bruno Martins currently owns a total of 1 stock. Eduardo Bruno Martins owns 81,213 shares of Sagimet Biosciences Inc (SGMT) as of July 19, 2024, with a value of $267,191.
Latest Holdings of Eduardo Bruno Martins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc | 2024-07-19 | 81,213 | 3.29 | 267,191 |
Holding Weightings of Eduardo Bruno Martins
Eduardo Bruno Martins Form 4 Trading Tracker
According to the SEC Form 4 filings, Eduardo Bruno Martins has made a total of 1 transactions in Sagimet Biosciences Inc (SGMT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sagimet Biosciences Inc is the sale of 8,357 shares on July 19, 2024, which brought Eduardo Bruno Martins around $25,907.
Insider Trading History of Eduardo Bruno Martins
- 1
Eduardo Bruno Martins Trading Performance
Eduardo Bruno Martins Ownership Network
Eduardo Bruno Martins Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
Eduardo Bruno Martins is the SVP & Liver and Infectious Dise of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, Eduardo Bruno Martins made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
Eduardo Bruno Martins Mailing Address
Above is the net worth, insider trading, and ownership report for Eduardo Bruno Martins. You might contact Eduardo Bruno Martins via mailing address: 350 Cambridge Ave, Suite 350, Palo Alto Ca 94306.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
